ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J07BC01 | G | Hepatitis B, purified surface antigen adsorbed on aluminium hydroxide (Al+++) (0.50mg to 0.80mg) - 20mcg/ml | 8452 | 167615/10 | HEPATITIS-B VACCINE (r DNA) ADULT | 20mcg/ml | 1 | Injectable suspension | IM | Unipharm S.A.L. | Serum Institute of India Ltd | India | 375,165 L.L | 23.08 | A2 | Serum Institute of India Ltd | India | 2/1/2023 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J07BC01 | B | Hepatitis B, purified antigen - 20mcg/ml | 32 | 26275 | ENGERIX-B 20 | 20mcg/ml | 1dose x 1ml | Injectable suspension | IM | Abela Frères S.A.L. | GlaxoSmithKline Biologicals SA | Belgium | 471,982 L.L | 23.08 | B | GlaxoSmithKline Biologicals SA | Belgium | 2/1/2023 |